[go: up one dir, main page]

KR900008168B1 - Novel radio pharmaceuticals and chelating agents useful in their preparation - Google Patents

Novel radio pharmaceuticals and chelating agents useful in their preparation

Info

Publication number
KR900008168B1
KR900008168B1 KR8505136A KR850005136A KR900008168B1 KR 900008168 B1 KR900008168 B1 KR 900008168B1 KR 8505136 A KR8505136 A KR 8505136A KR 850005136 A KR850005136 A KR 850005136A KR 900008168 B1 KR900008168 B1 KR 900008168B1
Authority
KR
South Korea
Prior art keywords
preparation
chelating agents
agents useful
novel radio
radio pharmaceuticals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR8505136A
Other languages
Korean (ko)
Other versions
KR870000935A (en
Inventor
Nicholas S Bodor
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Publication of KR870000935A publication Critical patent/KR870000935A/en
Application granted granted Critical
Publication of KR900008168B1 publication Critical patent/KR900008168B1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Conversion Of X-Rays Into Visible Images (AREA)
  • Luminescent Compositions (AREA)
  • Glass Compositions (AREA)

Abstract

Pyridinium, quinolinium and isoquinolinium salts of formula (I) are prepared. In (I), A= residue of a chelating agent capable of chelating with ametallic radiomucleotide and having at least one p-, s- or t-amino functional gp., this gp. not being essential for the complexing properties; the residue is characterized by the absence of at least one of the p-, s-, t-amino functional gp.; y= 1 or 2; B= gp. of formula (II), (III) or (IV), each attached through the N atom; n, p, q= 0, 1 or 2; R= halogen, C1-7 alkyl, C1-7 alkoxy, C2-8 alkoxycarbonyl, etc.; X= anion of inorgainc acid; t= valence of the anion; S= integer; and S times t=y.
KR8505136A 1984-07-19 1985-07-18 Novel radio pharmaceuticals and chelating agents useful in their preparation Expired KR900008168B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63238384A 1984-07-19 1984-07-19
US632383 1990-12-21

Publications (2)

Publication Number Publication Date
KR870000935A KR870000935A (en) 1987-03-10
KR900008168B1 true KR900008168B1 (en) 1990-11-05

Family

ID=24535323

Family Applications (1)

Application Number Title Priority Date Filing Date
KR8505136A Expired KR900008168B1 (en) 1984-07-19 1985-07-18 Novel radio pharmaceuticals and chelating agents useful in their preparation

Country Status (14)

Country Link
EP (1) EP0191788A1 (en)
JP (1) JPS61112054A (en)
KR (1) KR900008168B1 (en)
AU (1) AU4632085A (en)
CA (1) CA1266864A (en)
DK (1) DK124686A (en)
ES (2) ES8700236A1 (en)
FI (1) FI861119A7 (en)
GR (1) GR851793B (en)
IL (1) IL75845A0 (en)
NO (1) NO860980L (en)
PT (1) PT80842B (en)
WO (1) WO1986000897A1 (en)
ZA (1) ZA855477B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322876A3 (en) * 1987-12-29 1990-09-05 Nihon Medi-Physics Co., Ltd. Chelating compounds and their use
SE526214C2 (en) * 2003-02-28 2005-07-26 Amersham Biosciences Ab One way to generate metal chelating affinity ligands
KR101033209B1 (en) * 2004-12-31 2011-05-06 주식회사 효성 Manufacturing method of polyester powder spun yarn with improved sprayability

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444690A (en) * 1982-02-25 1984-04-24 University Patents, Inc. Technetium chelates
EP0110955B1 (en) * 1982-05-18 1995-08-23 University Of Florida Brain-specific drug delivery

Also Published As

Publication number Publication date
PT80842A (en) 1985-08-01
PT80842B (en) 1987-05-27
ES545395A0 (en) 1986-10-01
GR851793B (en) 1985-11-26
KR870000935A (en) 1987-03-10
IL75845A0 (en) 1985-11-29
ZA855477B (en) 1987-03-25
DK124686D0 (en) 1986-03-18
NO860980L (en) 1986-05-06
FI861119A0 (en) 1986-03-18
ES8705389A1 (en) 1987-05-01
CA1266864A (en) 1990-03-20
FI861119A7 (en) 1986-03-18
DK124686A (en) 1986-05-20
ES552090A0 (en) 1987-05-01
EP0191788A1 (en) 1986-08-27
AU4632085A (en) 1986-02-25
ES8700236A1 (en) 1986-10-01
JPS61112054A (en) 1986-05-30
WO1986000897A1 (en) 1986-02-13

Similar Documents

Publication Publication Date Title
ES459497A1 (en) N(Aminoalkyl)-naphthalimides and their derivatives
MY129863A (en) Biocidal composition
RO80925B (en) Process for the preparation of nitrothiophen derivatives
KR900008168B1 (en) Novel radio pharmaceuticals and chelating agents useful in their preparation
ES421430A1 (en) Carbostyril derivatives and process for preparing the same
IE37269B1 (en) 1-aminosulphonyl-2-aminobenzimidazoles process for their preparation and their fungicidal use
AU579116B2 (en) Use of quinoline derivatives for the protection of cultivated plants
ES8505955A1 (en) Novel 5-acyl-2-(1H)-pyridinones.
EP0267970A4 (en) Novel biphenyl derivatives, process for their preparation, and their use.
ES8101539A1 (en) Indanamine derivatives, process for their preparation and medicaments containing them.
JPS5430183A (en) 3,4-dihydrocarbostyril derivative
GB1507414A (en) Hydantoin derivatives
IE780982L (en) 4-hydroxythiazoline-2-thiones.
ES479928A1 (en) 9.9-Dimethyl-6.7-benzomorphan derivatives, processes for their preparation and pharmaceutical compositions comprising them.
EP0147788A3 (en) Phenylacetanilide derivatives
IE38982B1 (en) Novel aminobenzhydroxamic acids and their salts, a process for their preparation and their fungicidal and microbicidal use
GB1498499A (en) Benzotriazines
DE3462137D1 (en) Thiolactic acid derivative with bronchosecretolitic activity
ES8203223A1 (en) Treatment of glaucoma
GB1210034A (en) NOVEL p-CARBAMOYLAMINOPHENOL ETHERS, PROCESSES FOR THEIR PREPARATION, AND COMPOSITIONS INCORPORATING THEM
GB1426666A (en) Pyridine derivatives their preparation and pharmaceutical composi ions containing them
ES440950A1 (en) Derivatives of tetralone and the preparation thereof
ES472071A1 (en) Intermediate for synthesis: glycerylanthranilate and process for its preparation.
GB1065617A (en) Nitrofuran derivatives
JPS51125242A (en) Process for preparing bis-(benzamido)- benzene derivatives

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19850718

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19870924

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19850718

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19900406

Patent event code: PE09021S01D

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19901008

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19910124

NORF Unpaid initial registration fee
PC1904 Unpaid initial registration fee